Azelis
Speciality chemical distributor Azelis has partnered with JH Nanhang (JHNH) and signed an exclusive agreement to supply its range of polyvinylpyrolidones (PVPs) for all pharmaceutical applications across Europe, Turkey, Russia, Tunisia, Morocco and Algeria.
JHNH is a leading PVP manufacturer in China with an annual production of 5,000 mt. The company meets all international standards for quality and safety, including cGMP, ISO 9001 and ISO 14001 certifications. The company's pharmaceutical products, marketed under the trade name Povidone, are fully qualified, conforming to USP/EP/JP with drug master files available.
This deal is seen as a very positive move from both sides. The two companies have a shared vision to drive market expansion and sustainable business development by providing high quality products, backed by responsive customer care.
Dr. Tan Tiow Lin, General Manager, Global Sales and Marketing JHNH, explained: “Azelis is recognised for dedicated sales, marketing, technical support and supply chain excellence in the pharmaceutical industry. At JHNH, we look forward to working with the Azelis pharma team to provide customers with in-depth application insight, helping to improve product performance and optimise cost effectiveness.”
Matthew Dickman, International Business Director, Azelis Pharma, added: “Azelis is excited about this opportunity to help drive JHNH’s strategy to penetrate western markets. I am certain that this agreement will strengthen both our businesses across Europe, Russia, Turkey and North Africa, whilst at the same time give our customers access to all that this key Chinese manufacturer can offer.”
The Povidone pharmaceutical range is suitable for a wide variety of applications, including binders and stabilisers for tablets, film formers and solubilisers for injection preparations and disintegrants for tablets, capsules and granules. To support their introduction, Azelis plans to provide prototype formulations and laboratory support, inviting customers for product training days and laboratory visits.
All products are covered by a confirmation letter of REACH pre-registration.
Azelis, matthew.dickman@azelis.com, www.azelis.com.